Anhedonia clinical trials

Explore recruiting anhedonia clinical trials.

Recruiting anhedonia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Anhedonia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Psilocybin's effects on anhedonia

Austria

Human Pharmacology (Phase I)- Other EU CTIS Study details

Psilocybin's effects on anhedonia

Austria

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 3, Randomized, Double blind, Placebo controlled Study to Evaluate the Effects of Oral NMRA-335140 versus Placebo in Participants with Major Depressive Disorder

Germany, Bulgaria, Czechia, France, Finland, Sweden +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Advancing PRecise Interventions for resistant DEpression: rebalancing brain networks and investigating the trajectories of antidepressant effect with psilocybin and personalized neuromodulation (PRIDE)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of Azetukalner in Major Depressive Disorder

Finland, Poland, Romania, Slovakia, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Adjuvant treatment with Pramipexole for anhedonia symptoms in depression - PRIME-PRAXOL

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Anhedonia trials by city

Anhedonia in Toronto Anhedonia in Vancouver Anhedonia in Montreal Anhedonia in Calgary Anhedonia in Edmonton Anhedonia in Ottawa Anhedonia in Winnipeg Anhedonia in Quebec City Anhedonia in Hamilton Anhedonia in Kitchener Anhedonia in London Anhedonia in Halifax Anhedonia in New York Anhedonia in Los Angeles Anhedonia in Chicago Anhedonia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease